International Stem Cell Corporation
ISCO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $651 | $496 | $1,441 | $3,682 |
| - Cash | $1,230 | $1,588 | $742 | $171 |
| + Debt | $3,840 | $4,178 | $4,275 | $4,072 |
| Enterprise Value | $3,261 | $3,086 | $4,974 | $7,583 |
| Revenue | $9,085 | $7,789 | $8,180 | $7,176 |
| % Growth | 16.6% | -4.8% | 14% | – |
| Gross Profit | $5,321 | $4,608 | $4,911 | $4,241 |
| % Margin | 58.6% | 59.2% | 60% | 59.1% |
| EBITDA | $142 | $202 | $22 | -$220 |
| % Margin | 1.6% | 2.6% | 0.3% | -3.1% |
| Net Income | -$209 | -$131 | -$466 | -$1,040 |
| % Margin | -2.3% | -1.7% | -5.7% | -14.5% |
| EPS Diluted | -0.026 | -0.016 | -0.058 | -0.13 |
| % Growth | -59.1% | 71.8% | 55.2% | – |
| Operating Cash Flow | $13 | $929 | $332 | -$1,297 |
| Capital Expenditures | -$166 | -$83 | -$11 | -$45 |
| Free Cash Flow | -$153 | $846 | $321 | -$1,342 |